Eva Ulrike GRAEFE-MODY,Thomas KLEIN,Michael MARK,Hans-Juergen WOERLE
申请号：
US16196592
公开号：
US20200155558A1
申请日:
2018.11.20
申请国别(地区):
US
年份:
2020
代理人:
摘要：
The present invention relates to the finding that certain DPP-4 inhibitors are particularly suitable for treating and/or preventing metabolic diseases, particularly diabetes, in patients with insufficient glycemic control despite a therapy with an oral and/or a non-oral antidiabetic drug.
